Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,119.58
(
0.79%
)
US TECH 100
26,115.20
(
1.33%
)
Dow Jones
49,449.87
(
0.00%
)
Brent Oil
97.24
(
2.34%
)
Bitcoin
78,835.52
(
3.29%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: urche post# 111863

Monday, 08/04/2014 12:31:53 PM

Monday, August 04, 2014 12:31:53 PM

Post# of 257437
Roche acquires Santaris Pharma (private) for $200M in cash plus contingent payments:

http://www.roche.com/media/media_releases/med-cor-2014-08-04.htm

Roche announced today that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics.

Santaris has been around for quite a while—see #msg-27943365 re a 2008 paper in Nature on the LNA platform.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now